Senna With Docusate (red)

Generic Name: senna with docusate (red)

Over-the-Counter (OTC)

Dosage form: TABLET. Active ingredients: DOCUSATE (50 mg/1); SENNA ALATA LEAF (8.6 mg/1). Category: DRUG FOR FURTHER PROCESSING.

Overview

Dosage form: TABLET. Active ingredients: DOCUSATE (50 mg/1); SENNA ALATA LEAF (8.6 mg/1). Category: DRUG FOR FURTHER PROCESSING.

Dosage

Available as tablet.

Related Medications

Rituximab-abbs

rituximab-abbs

CD20-directed Cytolytic Antibody [EPC]

11 DESCRIPTION Rituximab-abbs is a genetically engineered chimeric murine/human monoclonal IgG1 kappa antibody directed against the CD20 antigen. Rituximab-abbs has an approximate molecular weight of 145 kD. Rituximab-abbs is produced by mammalian cell (Chinese Hamster Ovary) suspension culture in a nutrient medium. TRUXIMA (rituximab-abbs) injection is a sterile, clear to opalescent, colorless to pale yellow, preservative-free solution for intravenous infusion.

Eucalyptus Globulus, Lung (bovine), Sanguinaria Canadensis, Adrenalinum, Belladonna

eucalyptus globulus, lung (bovine), sanguinaria canadensis, adrenalinum, belladonna

alpha-Adrenergic Agonist [EPC]

PURPOSE: Adrenalinum – Miner Breathing Issues, Excess Mucus and Lung Support,† Belladonna – Minor Breathing Issues and Lung Support,† Eucalyptus Globulus - Miner Breathing Issues, Excess Mucus and Lung Support,† Lung – Lung Support,† Sanguinaria Canadensis – Minor Breathing Issues, Cough and Lung Support.† †Claims based on traditional homeopathic practice, not accepted medical evidence. Not FDA evaluated.

Nebivolol Hydrochloride

nebivolol hydrochloride

11 DESCRIPTION The chemical name for the active ingredient in Nebivolol Tablets is (αR,α'R,2R,2'S)-rel-α,α'-[iminobis(methylene)]bis[6-fluoro-3,4 dihydro-2H-1-Benzopyran-2-methanol] hydrochloride. Nebivolol is a racemate composed of d-Nebivolol and l-Nebivolol with the stereochemical designations of [SRRR]-nebivolol and [RSSS]-nebivolol, respectively.

Medical Disclaimer

This drug information is for educational purposes only and should not replace professional medical advice. Drug information is sourced from the FDA National Drug Code Directory and Structured Product Labeling. Always consult with a healthcare provider before starting, stopping, or changing any medication.